Healthcare provider profile · identity verified

Matthew Thomas Long, D.O.

Family Practice · LONG BEACH, CA · NPI 1851406243

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	876	279
Amlodipine Besylate	Amlodipine Besylate	629	183
Losartan Potassium	Losartan Potassium	465	142
Levothyroxine Sodium	Levothyroxine Sodium	441	124
Metformin Hcl	Metformin Hcl	398	119
Lisinopril	Lisinopril	335	109
Gabapentin	Gabapentin	289	97
Furosemide	Furosemide	275	79
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	255	50
Tamsulosin Hcl	Tamsulosin Hcl	246	76
Simvastatin	Simvastatin	212	61
Tramadol Hcl	Tramadol Hcl	169	62
Omeprazole	Omeprazole	161	72
Trazodone Hcl	Trazodone Hcl	159	51
Metoprolol Succinate	Metoprolol Succinate	153	53
Azithromycin	Azithromycin	146	112
Meloxicam	Meloxicam	145	57
Zolpidem Tartrate	Zolpidem Tartrate	142	23
Pantoprazole Sodium	Pantoprazole Sodium	140	56
Albuterol Sulfate Hfa	Albuterol Sulfate	138	43
Hydrochlorothiazide	Hydrochlorothiazide	134	36
Metoprolol Tartrate	Metoprolol Tartrate	130	24
Atenolol	Atenolol	129	43
Fluticasone Propionate	Fluticasone Propionate	123	57
Januvia	Sitagliptin Phosphate	121	33
Montelukast Sodium	Montelukast Sodium	119	29
Benazepril Hcl	Benazepril Hcl	112	29
Ibuprofen	Ibuprofen	112	42
Citalopram Hbr	Citalopram Hydrobromide	111	34
Lorazepam	Lorazepam	101	15
Carvedilol	Carvedilol	97	33
Alprazolam	Alprazolam	95	19
Lovastatin	Lovastatin	90	27
Baclofen	Baclofen	82	56
Donepezil Hcl	Donepezil Hcl	82	24
Sertraline Hcl	Sertraline Hcl	82	20
Pioglitazone Hcl	Pioglitazone Hcl	81	29
Eliquis	Apixaban	80	31
Hydralazine Hcl	Hydralazine Hcl	80	11
Jardiance	Empagliflozin	77	21
Alendronate Sodium	Alendronate Sodium	74	20
Rosuvastatin Calcium	Rosuvastatin Calcium	73	27
Finasteride	Finasteride	72	22
Olmesartan Medoxomil	Olmesartan Medoxomil	70	21
Ozempic	Semaglutide	69	12
Allopurinol	Allopurinol	66	27
Oxybutynin Chloride Er	Oxybutynin Chloride	64	19
Famotidine	Famotidine	63	22
Glipizide	Glipizide	61	19
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	60	11
Solifenacin Succinate	Solifenacin Succinate	58	18
Duloxetine Hcl	Duloxetine Hcl	56	19
Triamcinolone Acetonide	Triamcinolone Acetonide	56	43
Escitalopram Oxalate	Escitalopram Oxalate	55	12
Clonidine Hcl	Clonidine Hcl	51	20
Clopidogrel	Clopidogrel Bisulfate	50	20
Ezetimibe	Ezetimibe	49	16
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	48	16
Pregabalin	Pregabalin	48	16
Clonazepam	Clonazepam	45	17
Carisoprodol	Carisoprodol	44	suppressed
Synthroid	Levothyroxine Sodium	44	16
Naproxen	Naproxen	41	19
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	40	34
Dicyclomine Hcl	Dicyclomine Hcl	40	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	40	14
Hydrocortisone	Hydrocortisone	39	23
Chlorthalidone	Chlorthalidone	37	11
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	36	15
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	36	29
Diclofenac Sodium	Diclofenac Sodium	35	15
Memantine Hcl	Memantine Hcl	35	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	34	13
Etodolac	Etodolac	34	13
Methylprednisolone	Methylprednisolone	34	30
Meclizine Hcl	Meclizine Hcl	33	16
Valacyclovir	Valacyclovir Hcl	33	13
Sildenafil Citrate	Sildenafil Citrate	32	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	31	22
Propranolol Hcl	Propranolol Hcl	31	suppressed
Trulicity	Dulaglutide	31	suppressed
Ropinirole Hcl	Ropinirole Hcl	30	11
Acyclovir	Acyclovir	29	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	28	15
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	28	suppressed
Potassium Chloride	Potassium Chloride	28	suppressed
Bupropion Xl	Bupropion Hcl	27	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	27	14
Fluoxetine Hcl	Fluoxetine Hcl	27	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	27	suppressed
Xarelto	Rivaroxaban	27	suppressed
Diltiazem Hcl	Diltiazem Hcl	26	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	26	suppressed
Valsartan	Valsartan	26	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	25	suppressed
Buspirone Hcl	Buspirone Hcl	24	suppressed
Ondansetron Hcl	Ondansetron Hcl	24	16
Prednisone	Prednisone	24	11
Azelastine Hcl	Azelastine Hcl	23	suppressed
Dutasteride	Dutasteride	23	12
Pravastatin Sodium	Pravastatin Sodium	23	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	23	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	22	suppressed
Bupropion Hcl Sr	Bupropion Hcl	22	suppressed
Glimepiride	Glimepiride	22	suppressed
Nabumetone	Nabumetone	22	11
Nifedipine Er	Nifedipine	22	suppressed
Metformin Hcl Er	Metformin Hcl	21	suppressed
Mirtazapine	Mirtazapine	21	suppressed
Breyna	Budesonide/Formoterol Fumarate	20	suppressed
Indomethacin	Indomethacin	20	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	20	18
Mupirocin	Mupirocin	19	14
Nortriptyline Hcl	Nortriptyline Hcl	19	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	18	suppressed
Terazosin Hcl	Terazosin Hcl	18	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	17	16
Lantus	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Levofloxacin	Levofloxacin	17	11
Testosterone	Testosterone	17	suppressed
Eszopiclone	Eszopiclone	16	suppressed
Fenofibrate	Fenofibrate	16	suppressed
Temazepam	Temazepam	16	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	15	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	15	12
Hydroxyzine Hcl	Hydroxyzine Hcl	15	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	15	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	15	suppressed
Rybelsus	Semaglutide	15	suppressed
Spironolactone	Spironolactone	15	suppressed
Fluconazole	Fluconazole	14	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	14	suppressed
Ambien Cr	Zolpidem Tartrate	13	suppressed
Digoxin	Digoxin	13	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Indapamide	Indapamide	13	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	13	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	13	13
Quetiapine Fumarate	Quetiapine Fumarate	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Chlordiazepoxide Hcl	Chlordiazepoxide Hcl	12	suppressed
Invega Sustenna	Paliperidone Palmitate	12	suppressed
Lidocaine	Lidocaine	12	suppressed
Linzess	Linaclotide	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Tizanidine Hcl	Tizanidine Hcl	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Entresto	Sacubitril/Valsartan	11	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Megestrol Acetate	Megestrol Acetate	11	suppressed
Myrbetriq	Mirabegron	11	suppressed
Telmisartan	Telmisartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error